← SynDRA
ERASTIN
SynDRA canonical compound SYN0008865 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | VDAC2 |
| Mechanism of action | Ion channel antagonist |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- 2-[1-[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone
- 2-(1-(4-(2-(4-chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4(3H)-one
- 2-[1-[4-[2-(4-chlorophenoxy)acetyl]piperazin-1-yl]ethyl]-3-(2-ethoxyphenyl)quinazolin-4-one
- 2-(1-(4-(2-(4-Chlorophenoxy)acetyl)-1-piperazinyl)ethyl)-3-(2-ethoxyphenyl)-4(3H)-quinazolinone
- 2-(1-(4-(2-(4-Chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4-one
- MFCD09837984
- ZJA3NS42T9
- CHEMBL401989
- SCHEMBL4457820
- Erastin, >=98% (HPLC)
- CHEBI:94287
- DTXSID80458949
- EX-A295
- HMS3653K21
- HMS3868M03
- BCP27907
- WXA20378
- BDBM50376126
- s7242
- AKOS025147365
- CCG-269987
- CS-1675
- Erastin - CAS 571203-78-6
- SB19588
- NCGC00351608-10
- NCGC00351608-14
- AC-35446
- AS-55898
- DA-42059
- HY-15763
- E7781
- FT-0700333
- SW208651-2
- C21478
- E-7781
- A869751
- BRD-A25004090-001-01-9
- BRD-A25004090-001-02-7
Look up ERASTIN in the interactive SynDRA portal →